Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ELVA
ELVA logo

ELVA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Electrovaya Inc (ELVA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
7.890
1 Day change
3.14%
52 Week Range
11.880
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Electrovaya Inc (ELVA) is not a strong buy at this moment for a beginner investor with a long-term strategy. While the stock has a bullish moving average trend and a raised price target from analysts, the lack of immediate positive catalysts, weak financial performance in Q1 2026, and absence of proprietary trading signals suggest waiting for more clarity or stronger entry points.

Technical Analysis

The stock's technical indicators show a bullish moving average trend (SMA_5 > SMA_20 > SMA_200), a neutral RSI at 38.609, and a positive MACD histogram of 0.022. However, the stock is trading below the pivot level of 8.06, with key support at 7.464 and resistance at 8.656.

Options Data

Bearish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
7

Positive Catalysts

  • Analyst from Roth Capital raised the price target to $10 from $7, citing the commissioning of cell production at the Jamestown facility in 2026 as a transformational event. Revenue grew by 39.26% YoY in Q1 2026.

Neutral/Negative Catalysts

  • No significant hedge fund or insider trading trends. No recent news or congress trading data available.

Financial Performance

In Q1 2026, revenue increased to $15.55M (+39.26% YoY), but net income dropped to $1.038M (-347.14% YoY), and EPS fell to 0.02 (-300.00% YoY). Gross margin improved to 30.22% (+9.22% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Roth Capital maintains a Buy rating and raised the price target to $10 from $7, citing future growth potential tied to the Jamestown facility commissioning in late 2026.

Wall Street analysts forecast ELVA stock price to rise
5 Analyst Rating
Wall Street analysts forecast ELVA stock price to rise
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 7.650
sliders
Low
7
Averages
10.13
High
14
Current: 7.650
sliders
Low
7
Averages
10.13
High
14
Roth Capital
NULL -> Buy
upgrade
$7 -> $10
AI Analysis
2026-02-13
Reason
Roth Capital
Price Target
$7 -> $10
AI Analysis
2026-02-13
upgrade
NULL -> Buy
Reason
Roth Capital raised the firm's price target on Electrovaya to $10 from $7 and keeps a Buy rating on the shares. The commissioning of cell production at Electrovaya's Jamestown, NY, facility towards the end of calendar 2026 will likely be a transformational moment for the company, the analyst tells investors in a research note.
Oppenheimer
Outperform
initiated
$14
2025-12-18
Reason
Oppenheimer
Price Target
$14
2025-12-18
initiated
Outperform
Reason
Oppenheimer initiated coverage of Electrovaya with an Outperform rating and $14 price target. The firm says Electrovaya is a leading battery technology platform with "defensible" intellectual property in materials design, manufacturing, and handling. The company is well positioned to scale through the material handling market and become a critical enabler of autonomous mobile robot performance, the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for ELVA
Unlock Now

People Also Watch